Ionis Pharmaceuticals is a biotech company specializing in RNA-targeted therapies, using antisense technology to treat genetic diseases. Based in Carlsbad, California, Ionis developed key drugs like Spinraza (for SMA), Wainua (for amyloidosis), and Tryngolza (for FCS). It has a broad pipeline in neurology, cardiology, and rare diseases, and is shifting toward independent drug commercialization.
| Company | Catalyst | Successful? | Gain/Loss (%) | Chart | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IONS | Episodic Pivot | July 30, 2025 | 2 | Choppy | Earnings Report |
❌
|
-2.4% | Detail https://breakoutdb.com/ions/ions-episodic-pivot-2025-07-30/ |
(*) This trade is still active; the gain is an estimate based on the current price.
